| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.4 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.4 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.4 |